Hereditary nonpolyposis colorectal cancer historical perspective
Jump to navigation
Jump to search
|
Hereditary Nonpolyposis Colorectal Cancer Microchapters |
|
Differentiating Hereditary Nonpolyposis Colorectal Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hereditary nonpolyposis colorectal cancer historical perspective On the Web |
|
American Roentgen Ray Society Images of Hereditary nonpolyposis colorectal cancer historical perspective |
|
FDA on Hereditary nonpolyposis colorectal cancer historical perspective |
|
CDC on Hereditary nonpolyposis colorectal cancer historical perspective |
|
Hereditary nonpolyposis colorectal cancer historical perspective in the news |
|
Blogs on Hereditary nonpolyposis colorectal cancer historical perspective |
|
Directions to Hospitals Treating Hereditary nonpolyposis colorectal cancer |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Maria Fernanda Villarreal, M.D. [3]
Overview
Lynch syndrome was first described by Dr. Henry T. Lynch, an American physician, in 1966.
Historical Perspective
- In 1913, Aldred Warthin, Chairman of the Department of Pathology at the University of Michigan in Ann Arbor, first reported a family which he called 'Family G' with features of the disease now known as Lynch syndrome. He recognized there were "cancer fraternities" and there was an influence of heredity on cancer.[1]
- In 1966, Dr. Henry T. Lynch described 2 Midwestern families whose members were affected with colon, gastric, and endometrial cancers.[2]
- In 1971, Lynch and Krush updated the studies of the family, in which they introduced the term 'cancer family syndrome" for the disease affecting the families.[3]
- The term "Lynch syndrome" was coined in 1984 by Boland and Troncale.[4]
- Lynch named the condition "hereditary nonpolyposis colorectal cancer" in 1985. Since then the two terms have been used interchangeably. [5]
- Some sources reserve the term "Lynch syndrome" when there is a known DNA mismatch repair defect, and use the term "familial colorectal cancer type X" or "hereditary nonpolyposis colorectal cancer" when the Amsterdam criteria are met but there is no known DNA mismatch repair defect.[6]
- In 1991, the Amsterdam I Guidelines were published to help classify HNPCC.[7]
- In 1999, the updated Amsterdam II guidelines were published. [8]
- In 1997. Bethesda guidelines were published in which criteria for the identification of colorectal cancers that must be tested for microsatellite instability (MSI) were present.[9]
- The Bethesda guidelines were updated and revised in 2004.[10]
References
- ↑ C. Richard Boland & Henry T. Lynch (2013). "The history of Lynch syndrome". Familial cancer. 12 (2): 145–157. doi:10.1007/s10689-013-9637-8. PMID 23546821. Unknown parameter
|month=ignored (help) - ↑ Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ (Feb 1966). "Hereditary factors in cancer. Study of two large midwestern kindreds". Archives of Internal Medicine. 117 (2): 206–12. doi:10.1001/archinte.117.2.206. PMID 5901552.
- ↑ H. T. Lynch & A. J. Krush (1971). "The cancer family syndrome and cancer control". Surgery, gynecology & obstetrics. 132 (2): 247–250. PMID 5547406. Unknown parameter
|month=ignored (help) - ↑ C. R. Boland & F. J. Troncale (1984). "Familial colonic cancer without antecedent polyposis". Annals of internal medicine. 100 (5): 700–701. PMID 6712034. Unknown parameter
|month=ignored (help) - ↑ Bellizzi AM, Frankel WL (Nov 2009). "Colorectal cancer due to deficiency in DNA mismatch repair function: a review". Advances in Anatomic Pathology. 16 (6): 405–17. doi:10.1097/PAP.0b013e3181bb6bdc. PMID 19851131.
- ↑ Lindor NM (Oct 2009). "Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome". Surgical Oncology Clinics of North America. 18 (4): 637–45. doi:10.1016/j.soc.2009.07.003. PMC 3454516. PMID 19793571.
- ↑ H. F. Vasen, J. P. Mecklin, P. M. Khan & H. T. Lynch (1991). "The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)". Diseases of the colon and rectum. 34 (5): 424–425. PMID 2022152. Unknown parameter
|month=ignored (help) - ↑ H. F. Vasen, P. Watson, J. P. Mecklin & H. T. Lynch (1999). "New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC". Gastroenterology. 116 (6): 1453–1456. PMID 10348829. Unknown parameter
|month=ignored (help) - ↑ M. A. Rodriguez-Bigas, C. R. Boland, S. R. Hamilton, D. E. Henson, J. R. Jass, P. M. Khan, H. Lynch, M. Perucho, T. Smyrk, L. Sobin & S. Srivastava (1997). "A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines". Journal of the National Cancer Institute. 89 (23): 1758–1762. PMID 9392616. Unknown parameter
|month=ignored (help) - ↑ Asad Umar, C. Richard Boland, Jonathan P. Terdiman, Sapna Syngal, Albert de la Chapelle, Josef Ruschoff, Richard Fishel, Noralane M. Lindor, Lawrence J. Burgart, Richard Hamelin, Stanley R. Hamilton, Robert A. Hiatt, Jeremy Jass, Annika Lindblom, Henry T. Lynch, Paivi Peltomaki, Scott D. Ramsey, Miguel A. Rodriguez-Bigas, Hans F. A. Vasen, Ernest T. Hawk, J. Carl Barrett, Andrew N. Freedman & Sudhir Srivastava (2004). "Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability". Journal of the National Cancer Institute. 96 (4): 261–268. PMID 14970275. Unknown parameter
|month=ignored (help)